#1 Clinical Trials Search in Europe

Prednisone

Prednisone, a widely used corticosteroid medication, has been the subject of numerous clinical trials exploring its effectiveness in treating various conditions. This article examines recent studies investigating prednisone’s use in managing diseases such as asthma, lupus, rheumatoid arthritis, heart failure, and chronic obstructive pulmonary disease (COPD). We’ll look at different formulations, dosages, and potential benefits of prednisone across these diverse medical applications.

Table of Contents

What is Prednisone?

Prednisone is a medication that belongs to a class of drugs called corticosteroids or glucocorticoids. It is a synthetic version of cortisol, a hormone naturally produced by the adrenal glands in your body. Prednisone is widely used for its powerful anti-inflammatory and immunosuppressive properties[1].

This medication is available under various brand names, including Cortancyl and Decortin H. It’s important to note that prednisone is different from prednisolone, which is another corticosteroid medication[2][3].

Conditions Treated with Prednisone

Prednisone is used to treat a wide range of conditions, including:

  • Rheumatoid Arthritis (RA): A chronic inflammatory disorder affecting the joints[1]
  • Systemic Lupus Erythematosus (SLE): An autoimmune disease that can affect various parts of the body[4]
  • Multiple Myeloma: A type of blood cancer that affects plasma cells[5][6]
  • Asthma: A condition that affects the airways and causes breathing difficulties[3]
  • Calcium Pyrophosphate Deposition (CPPD) Arthritis: Also known as pseudogout, a type of arthritis caused by crystal deposits in the joints[2]
  • Achalasia: A rare disorder of the esophagus that makes it difficult to swallow food[7]

How Prednisone Works

Prednisone works by mimicking the effects of cortisol in your body. It reduces inflammation and suppresses the immune system, which can help alleviate symptoms in various conditions[1].

In conditions like rheumatoid arthritis, prednisone helps reduce joint pain, swelling, and stiffness. For asthma patients, it can help reduce airway inflammation and improve breathing[3].

In blood cancers like multiple myeloma, prednisone is often used in combination with other drugs to help kill cancer cells and reduce inflammation[5].

Dosage Forms and Administration

Prednisone is available in several forms:

  • Oral tablets: These come in various strengths, typically ranging from 1 mg to 20 mg[2]
  • Modified-release tablets: These are designed to release the medication at specific times, which can be helpful for conditions with symptoms that worsen at night or early morning[3]

The dosage and duration of treatment can vary greatly depending on the condition being treated and the individual patient’s response. For example:

  • For rheumatoid arthritis, doses may range from 5 mg to 10 mg daily[1]
  • For acute CPPD arthritis, a dose of 20 mg daily might be used[2]
  • In multiple myeloma treatment, prednisone might be given at 60 mg/m² for 4 days as part of a combination therapy[5]

It’s crucial to follow your doctor’s instructions carefully when taking prednisone. Never stop taking the medication abruptly without medical supervision, as this can lead to withdrawal symptoms.

Potential Side Effects

While prednisone can be very effective, it can also cause side effects, especially when used at higher doses or for long periods. Some potential side effects include[2]:

  • Gastrointestinal issues: Nausea, vomiting, abdominal pain
  • Increased blood sugar levels
  • Sleep disturbances
  • Mood changes or irritability
  • Increased blood pressure
  • Changes in kidney function

Long-term use of prednisone may lead to more serious side effects, such as osteoporosis, increased risk of infections, and adrenal suppression. Your doctor will monitor you closely for these potential effects[1].

Ongoing Research and Clinical Trials

Researchers continue to study prednisone to better understand its effects and explore new uses. Some areas of ongoing research include:

  • Comparing prednisone to other treatments for various conditions, such as colchicine for CPPD arthritis[2]
  • Investigating modified-release formulations of prednisone for better management of nocturnal asthma symptoms[3]
  • Studying the effectiveness of prednisone in combination with other drugs for multiple myeloma treatment[8]
  • Exploring the use of prednisone in treating fatigue associated with systemic lupus erythematosus[4]

These ongoing studies aim to improve our understanding of prednisone and optimize its use in various medical conditions.

Condition Prednisone Formulation Key Findings/Objectives
Nocturnal Asthma Modified-release (Lodotra) Evaluated efficacy on nocturnal symptoms compared to immediate-release prednisone
Lupus Delayed-release (RAYOS) Compared effect on fatigue to immediate-release prednisone
Rheumatoid Arthritis Delayed-release (RAYOS) Assessed effectiveness on disease activity and morning stiffness
Heart Failure Standard prednisone Examined efficacy of different doses (15, 30, 60 mg/day) on diuresis
COPD Standard prednisone Studied effect on gene expression in stable COPD patients
Chondrocalcinosis (CPPD) Standard prednisone Compared efficacy and safety to colchicine for acute CPPD arthritis

FAQ

  • What conditions is prednisone being studied for in clinical trials? Recent clinical trials have explored prednisone's use in treating asthma, lupus, rheumatoid arthritis, heart failure, and chronic obstructive pulmonary disease (COPD).
  • Are there different formulations of prednisone being tested? Yes, studies have compared modified-release prednisone (like Lodotra or RAYOS) to immediate-release prednisone to assess their effectiveness in managing symptoms at different times of day.
  • How is prednisone's effectiveness measured in these trials? Effectiveness is measured through various means, including changes in disease activity scores, patient-reported symptoms, laboratory tests, and functional assessments specific to each condition being studied.
  • What are some potential benefits of prednisone being investigated? Potential benefits being studied include improved control of nocturnal asthma symptoms, reduced fatigue in lupus patients, better management of rheumatoid arthritis symptoms, enhanced diuresis in heart failure, and effects on gene expression in COPD.
  • Are there any comparisons being made between prednisone and other treatments? Some trials compare prednisone to other medications or treatment approaches. For example, one study compared colchicine to prednisone for treating acute calcium pyrophosphate deposition (CPPD) arthritis.

Ongoing Clinical Trials on Prednisone

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia Estonia France Germany Greece Hungary +9

  • Study Comparing Methylprednisolone and Methoxsalen for Treating Grade II Acute Graft-Versus-Host Disease in Adult Stem Cell Transplant Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Corticosteroids and Rituximab to Prevent Worsening of Ocular Myasthenia Gravis in Newly Diagnosed Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Portugal Spain

  • Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    Poland

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Lithuania Poland Romania +1

  • Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

    Recruiting

    3 1 1
    Investigated Drugs:
    France

  • Study on Transmural Healing in Patients with Moderate to Severe Crohn’s Disease Using Upadacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Germany Italy The Netherlands +2

Glossary

  • Prednisone: A corticosteroid medication used to treat various inflammatory conditions and autoimmune disorders.
  • Modified-release prednisone: A formulation of prednisone designed to release the medication at specific times, such as during the night, to better manage symptoms.
  • RAYOS: A brand name for delayed-release prednisone, used in some clinical trials for conditions like rheumatoid arthritis and lupus.
  • Lodotra: Another brand name for modified-release prednisone, studied for use in conditions like nocturnal asthma.
  • DAS28: Disease Activity Score in 28 Joints, a measure used to assess the activity of rheumatoid arthritis in clinical trials.
  • FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue, a tool used to measure fatigue in patients with chronic illnesses like lupus.
  • Acute exacerbation of COPD (AECOPD): A sudden worsening of COPD symptoms that often requires additional treatment or hospitalization.
  • Chondrocalcinosis: Also known as calcium pyrophosphate deposition (CPPD) disease, a condition where calcium crystals form in joint cartilage, causing arthritis-like symptoms.
  • Diuresis: Increased production of urine, often a goal in treating heart failure to reduce fluid overload.
  • Gene expression: The process by which information from a gene is used to create a functional gene product, often a protein.

References

  1. https://clinicaltrials.gov/study/NCT01393639
  2. https://clinicaltrials.gov/study/NCT03128905
  3. https://clinicaltrials.gov/study/NCT00686335
  4. https://clinicaltrials.gov/study/NCT03098823
  5. https://clinicaltrials.gov/study/NCT01063179
  6. https://clinicaltrials.gov/study/NCT00551928
  7. https://clinicaltrials.gov/study/NCT01903486
  8. https://clinicaltrials.eu/trial/study-comparing-bortezomib-melphalan-prednisone-lenalidomide-and-daratumumab-for-multiple-myeloma-in-patients-ineligible-for-stem-cell-transplant/